These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19020575)

  • 21. Cancer immunology: cat and mouse games.
    Melief CJ
    Nature; 2005 Sep; 437(7055):41-2. PubMed ID: 16136120
    [No Abstract]   [Full Text] [Related]  

  • 22. Tolerogenic dendritic cells for autoimmune disease and transplantation.
    Thomson AW; Robbins PD
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii90-6. PubMed ID: 19022823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
    Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
    Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel subset of CD8{alpha}+ dendritic cells localized in the marginal zone is responsible for tolerance to cell-associated antigens.
    Qiu CH; Miyake Y; Kaise H; Kitamura H; Ohara O; Tanaka M
    J Immunol; 2009 Apr; 182(7):4127-36. PubMed ID: 19299710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cryopreservation of monocytes is superior to cryopreservation of immature or semi-mature dendritic cells for dendritic cell-based immunotherapy.
    Hayden H; Friedl J; Dettke M; Sachet M; Hassler M; Dubsky P; Bachleitner-Hofmann T; Gnant M; Stift A
    J Immunother; 2009; 32(6):638-54. PubMed ID: 19483645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunological origin of autoimmune cytopenias].
    Bach JF; Viard JP
    Ann Med Interne (Paris); 1992; 143(6):358-60. PubMed ID: 1295384
    [No Abstract]   [Full Text] [Related]  

  • 27. Basic and clinical immunology meeting. An old favorite is resurrected: regulatory T cells take the stage.
    Couzin J
    Science; 2004 Aug; 305(5685):772. PubMed ID: 15297644
    [No Abstract]   [Full Text] [Related]  

  • 28. Expanding and converting regulatory T cells: a horizon for immunotherapy.
    Khattar M; Chen W; Stepkowski SM
    Arch Immunol Ther Exp (Warsz); 2009; 57(3):199-204. PubMed ID: 19479206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of costimulatory ligand CD70 on steady-state dendritic cells breaks CD8+ T cell tolerance and permits effective immunity.
    Keller AM; Schildknecht A; Xiao Y; van den Broek M; Borst J
    Immunity; 2008 Dec; 29(6):934-46. PubMed ID: 19062317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epistasis: the key to understanding immunological disease?
    Mitchison NA; Rose AM
    Eur J Immunol; 2011 Aug; 41(8):2152-4. PubMed ID: 21792875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracorporeal photochemotherapy.
    Maeda A
    J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B7-H1 up-regulation on dendritic-like leukemia cells suppresses T cell immune function through modulation of IL-10/IL-12 production and generation of Treg cells.
    Ge W; Ma X; Li X; Wang Y; Li C; Meng H; Liu X; Yu Z; You S; Qiu L
    Leuk Res; 2009 Jul; 33(7):948-57. PubMed ID: 19233469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immune tolerance of cancer is mediated by IDO that is inhibited by COX-2 inhibitors through regulatory T cells.
    Lee SY; Choi HK; Lee KJ; Jung JY; Hur GY; Jung KH; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
    J Immunother; 2009 Jan; 32(1):22-8. PubMed ID: 19307990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immune tolerance, anergy, suppressor T cells].
    Ishizaka K
    Ryumachi; 1994 Apr; 34(2):169-70. PubMed ID: 8202832
    [No Abstract]   [Full Text] [Related]  

  • 35. Human autoimmune thyroid disease--newer views on a common breakdown in T cell tolerance.
    Davies TF
    Isr J Med Sci; 1994 Mar; 30(3):2-11. PubMed ID: 8181920
    [No Abstract]   [Full Text] [Related]  

  • 36. Control of type 1 diabetes by CD4+Foxp3+ regulatory T cells: lessons from mouse models and implications for human disease.
    Sgouroudis E; Piccirillo CA
    Diabetes Metab Res Rev; 2009 Mar; 25(3):208-18. PubMed ID: 19214972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scientific rationale for the Finnish Allergy Programme 2008-2018: emphasis on prevention and endorsing tolerance.
    von Hertzen LC; Savolainen J; Hannuksela M; Klaukka T; Lauerma A; Mäkelä MJ; Pekkanen J; Pietinalho A; Vaarala O; Valovirta E; Vartiainen E; Haahtela T
    Allergy; 2009 May; 64(5):678-701. PubMed ID: 19383025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Special regulatory T-cell review: Suppressors regulated but unsuppressed.
    Kapp JA
    Immunology; 2008 Jan; 123(1):28-32. PubMed ID: 18154616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Old friends for breakfast.
    Rook GA; Brunet LR
    Clin Exp Allergy; 2005 Jul; 35(7):841-2. PubMed ID: 16008666
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
    González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
    Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.